Navigation Links
Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
Date:3/3/2008

FREMONT, Calif., March 3 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML), a high-value molecular diagnostics company, announced today that it has entered into an exclusive license agreement with Stanford University to develop and commercialize a novel biomarker panel used to assess the risk of peripheral artery disease (PAD). Estimated to affect up to 12 million Americans, PAD is a serious condition that often goes undiagnosed. The disease can result in severe complications, including gangrene, amputation, heart attack, stroke and even death.

Under the terms of the agreement, Vermillion is granted exclusive rights to the biomarker panel, and will undertake the development and commercialization of a PAD blood test, which utilizes the multi-marker panel to stratify an individual's risk for developing the disease.

"PAD is underdiagnosed and undertreated. We need new, innovative tools to aid in the diagnosis and management of this life and limb-threatening disease," said John Cooke, M.D., Ph.D., Professor of Medicine at Stanford University whose research has formed the basis of the Vermillion PAD blood test. "Through our successful venture with Vermillion, we are working to develop these essential tools to improve diagnosis, with the intent of expediting treatment and enhancing patient outcomes."

Gail Page, President and CEO of Vermillion, stated, "The license agreement with Stanford demonstrates our commitment to developing high-value molecular diagnostic products that aid in the management of complex diseases, such as PAD. We are confident that our collaboration with this distinguished research institution will continue to result in important clinical advances in the vascular arena."

In collaboration wi
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vermillion Receives NASDAQ Notice of Non-Compliance
2. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
3. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
4. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
5. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
6. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
7. Microchip Biotechnologies, Inc. Collaborating With Stanford University on Developing a Front End Microfluidic-Based Sample Preparation System for Pyrosequencing Platforms
8. Stanford researchers hear the sound of quantum drums
9. Maxygen to Present at the Stanford Group Company 13th Annual Healthcare Conference
10. Northeastern University and Mass General Hospital Increase the Accuracy, While Reducing the Diagnosis Time, for Breast Cancer Detection
11. Families of Spinal Muscular Atrophy; University of California, Irvine Stem Cell Scientist; and California Stem Cell Announce Collaboration for Safety Studies for Stem Cell Therapy in Spinal Muscular Atrophy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Seattle, WA (PRWEB) July 29, 2014 ... central IRB services, has been awarded accreditation by ... (IASSC) for its Lean Six Sigma Deployment ... eliminate waste and improve performance. , Quorum’s Lean ... granted the Accredited Deployment Program designation. The designation ...
(Date:7/29/2014)... CA (PRWEB) July 29, 2014 ... Pipette.com’s centrifugation product selection. Eppendorf 5427 R is geared ... and DNA – it is targeted towards work requiring ... Centrifuge 5427 R as it compliments their extensive 16, ... Eppendorf line of microcentrifuge tubes, PCR tubes, PCR strip ...
(Date:7/29/2014)... EXpressLO LLC, expert provider of focused ... solutions, has been granted patent number 8,789,826 by the ... incorporating a unique specimen carrier support grid design described ... company patent for EXpressLO LLC awarded to founder and ... complementary patents extend EXpressLO’s portfolio of intellectual property. The ...
(Date:7/28/2014)... July 28, 2014 The Workgroup for ... on the use of health IT to create efficiencies ... Plan Identifier (HPID) Workgroup has developed an issue ... Plan and Payer?” The HPID Workgroup, a part of ... the Centers for Medicare and Medicaid Services (CMS) to ...
Breaking Biology Technology:Quorum Review IRB Accredited by IASSC for Lean Six Sigma Deployment Program 2Quorum Review IRB Accredited by IASSC for Lean Six Sigma Deployment Program 3International Pipette Distributor, Pipette.com Announces the Addition of the Eppendorf Centrifuge 5427 R to Their Product Portfolio 2EXpressLO LLC Granted Second U.S. Patent for Innovative Specimen Preparation Methods 2WEDI’s HPID Workgroup Announces Release of Issue Brief: “What is the Difference Between a Health Plan and Payer?” 2
... VANCOUVER, Sept. 13 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. ... today that it received a,favourable decision from ... an attempt by Johnson & Johnson,s subsidiary, ... Zealand Patent 523799, which,pertains to compositions comprising ...
... ROCKVILLE, Md., Sept. 12 BioReliance Corporation, ... and,pharmaceutical industries, has contracted with Gentronix to ... a major part of BioReliance,s portfolio of,genotoxicity ... Ames,II assays, allows pharmaceutical companies to test ...
... 2007 Medical Products Industry Leader, DEERFIELD, Ill., Sept. ... today that it has been named 2007,Medical Products Industry ... and the Dow Jones Sustainability North America Index,(DJSI North ... has been listed in the DJSI and the sixth ...
Cached Biology Technology:Angiotech receives favourable patent decision from New Zealand's Intellectual Property Office 2Angiotech receives favourable patent decision from New Zealand's Intellectual Property Office 3Angiotech receives favourable patent decision from New Zealand's Intellectual Property Office 4BioReliance Launches Next-Generation Genotoxicity Screening Service 2Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year 2
(Date:7/29/2014)... from scientists at the University of Kent has shown ... are regulated a breakthrough that could have a ... from Kent,s School of Biosciences uncovered the mechanism whereby ... known as actin filaments are ,fine-tuned, to ... filaments appear to completely stable, providing a framework for ...
(Date:7/29/2014)... a rare disease it affects 1 in 100,000 people ... esophageal wall. While its cause remains unknown, a new study ... the University of Bonn in Germany and other European institutions ... origin. The study, published on 6 July in Nature ... disease. , When we swallow, a sphincter in the lower ...
(Date:7/28/2014)... the South Pole in 1911, but new research shows ... , Using data from 16 ice cores collected from ... South Pole, a group led by Joe McConnell of ... the most accurate and precise reconstruction to date of ... described in an article published today in the online ...
Breaking Biology News(10 mins):Mysterious esophagus disease is autoimmune after all 2Lead pollution beat explorers to South Pole, persists today 2Lead pollution beat explorers to South Pole, persists today 3
... the arteries weren't bad enough, a research team from the ... Newark has now confirmed that even our veins stiffen as ... are nice and elastic--like rubber bands," William Farquhar, a cardiovascular ... you grow older, we've found that your veins become more ...
... during periods of stress may increase the growth rate of ... that an increase in norepinephrine, a stress hormone, can stimulate ... down of the tissue around the tumor cells and allow ... there, they can travel to another location in the body ...
... first time, coaxed umbilical cord blood stem cells to differentiate into ... into a type of lung cell called type II alveolar cells. ... allows the air sacs in the lungs to remain open, allowing ... are also responsible for helping to repair the airway after injury. ...
Cached Biology News:Researchers show that veins stiffen as we age 2Researchers show that veins stiffen as we age 3Researchers show that veins stiffen as we age 4Stress hormones may play new role in speeding up cancer growth 2Stress hormones may play new role in speeding up cancer growth 3U of MN researchers turn cord blood into lung cells 2
... The SilverQuest Silver Staining Kit is ... staining sensitivity with minimal protein modification ... mass spectrometry problems associated with traditional ... SilverQuest kit because the reagents used ...
...
... Insect Medium is formuatled for the ... Sf9 and Sf21 cells. Grace's Insect ... because it does not contain lactalbumin ... with transfection. Grace's Insect Medium, Supplemented ...
Schneider's Drosophila Medium is formulated for the expression of heterologous proteins in Drosophila S2 cells....
Biology Products: